SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Helix Technology, a cold play on semiconductor equipment
HELX 36.78+3.3%Nov 21 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: mopgcw who wrote (1080)4/17/2003 10:01:40 PM
From: mopgcw  Read Replies (1) of 1227
 
CC Summary:

Reduced qrtly b/e rate $8 million from the mid-30's

cut los in half on flat revs; on plan to break-even

new prod platforms in both cti & gp gaining

protecting older platform mkt share for gp as well as new prod gains

on-board IS platform replacing older 300mm prod, achieved process qualification completion from major oem. this is a better price/cost position in addition to giving better performance to clients.

global customer serv: push out of several tool upgrades, but gaining momentum of transition to relationship contracts under true-blue (basic, performance & ultimate). new agreements closed in the US, EU and Japan.

Still pursuing expanding across the fab w/ both cti & gp

sales unchanged from q4; 16% higher than last yr

orders up 3% from q4

btb 1.0

semis = 63% of sales

cti 80%; gp 20%

global support 33% of revs compared to 35% q4 due to slow down of upgrades.

oem 50% of revs unchanged

17% to largest client

backlog of $6.2 million

515 employees/temps; < 500 fte

GM of 31.3% up from 28% due to improvement in manufacturing and reduction in overhead. as they move to on-board IS especially; w/ similar levels of revenue GM should improve further.

$27mm in R&D as they transitioned on-board IS & micro ion+ combination guage.

SGA down 12%

69.4mm in cash increase due to $11mm tax refund

recv increased and DSO of 66 days (vs 58) due to unusual skew of march orders that was a result of plant shutdowns in feb. should return to more normal levels.

no suspect accts

expect business stable in q2, flat to slightly improved given cost reductions; plant shutdowns may continue.

CIBC/Needham/Morgan stanley covered call/

litho market is an emerging opportunity for helx

cf op was negative $3-4 mm, but impacted due to recvables from late march orders.

very strong client position. q1 saw a real demonstration among both oem and end-user that evaluated other prods and went with helx

there are design-ins of on-board IS that will result in increased shipment

gp is gaining mkt share among second tier accts w/ the combination guage and replacement due to performance issues with a few major oems

implant area continues to see progress, but that is offset by weakness elsewhere

still expect $2mm/week run rate

current r&d level is appropriate for now

strong contribution from japan due to flat panels.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext